Neurocrine Biosciences | Vendas



Sales Alterar Data
AbbVie USD 15.42B 2.08B 2025-06
Acadia Pharmaceuticals USD 264.6M 20.28M 2025-06
Agios Pharmaceuticals USD 12.45M 3.75M 2025-06
ALKERMES USD 390.7M 84.2M 2025-06
Alnylam Pharmaceuticals USD 773.69M 179.5M 2025-06
Amgen USD 9.18B 1.03B 2025-06
Biogen USD 2.6B 170M 2025-06
BioMarin Pharmaceutical USD 825M 80M 2025-06
Cytokinetics USD 66.76M 65.16M 2025-06
Dynavax Technologies USD 95.44M 30.44M 2025-06
Exelixis USD 568.3M 12.9M 2025-06
Gilead Sciences USD 7.1B 430M 2025-06
Halozyme Therapeutics USD 206M 59M 2025-06
Incyte USD 1.06B 10M 2025-06
Ionis Pharmaceuticals USD 452M 320M 2025-06
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
Pfizer USD 14.7B 980M 2025-06
Prothena USD 2.12M 1.15M 2024-12
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Repligen USD 182M 13M 2025-06
Sarepta Therapeutics USD 611.09M 163.81M 2025-06
Teva Pharmaceutical Industries USD 14.06B 0 2025-06
Ultragenyx Pharmaceutical USD 166.5M 27.21M 2025-06
Vertex Pharmaceuticals USD 2.96B 190M 2025-06


Neurocrine Biosciences Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.